These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23116918)

  • 1. Closing immunization gaps in the U.S: how a little collusion could go a long way.
    Konstam J
    Virtual Mentor; 2012 Jan; 14(1):56-9. PubMed ID: 23116918
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating children whose parents refuse to have them vaccinated.
    Insel K
    Virtual Mentor; 2012 Jan; 14(1):17-22. PubMed ID: 23116911
    [No Abstract]   [Full Text] [Related]  

  • 3. New media, old messages: themes in the history of vaccine hesitancy and refusal.
    Schwartz JL
    Virtual Mentor; 2012 Jan; 14(1):50-5. PubMed ID: 23116917
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving cancer research. Leaders cite collaboration and increased areas of study as ways to fight the disease.
    Printz C
    Cancer; 2013 May; 119(10):1765-6. PubMed ID: 23649487
    [No Abstract]   [Full Text] [Related]  

  • 5. The NIH, research institutions and industry: working together on a shared goal.
    Omary MB
    Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
    [No Abstract]   [Full Text] [Related]  

  • 6. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
    Morin K; Morse LJ
    Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination: a victim of its own success.
    Janko M
    Virtual Mentor; 2012 Jan; 14(1):3-4. PubMed ID: 23116908
    [No Abstract]   [Full Text] [Related]  

  • 8. Is drug research trustworthy? The pharmaceutical industry funnels money to prominent scientists who are doing research that affects its products--and nobody can stop it.
    Seife C
    Sci Am; 2012 Dec; 307(6):56-63. PubMed ID: 23230798
    [No Abstract]   [Full Text] [Related]  

  • 9. Doctors and the drug industry: further thoughts for dealing with potential conflicts of interest?
    Alpert JS
    Am J Med; 2008 Apr; 121(4):253-5. PubMed ID: 18374678
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug companies, doctors and disclosures.
    Tuorto S; Chan MK; Adusumilli PS
    Natl Med J India; 2004; 17(4):215-6. PubMed ID: 15372772
    [No Abstract]   [Full Text] [Related]  

  • 11. American academy of pain medicine ethics council statement on conflicts of interest: interaction between physicians and industry in pain medicine.
    Dubois MY;
    Pain Med; 2010 Feb; 11(2):257-62. PubMed ID: 19930112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: business practices. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840
    [No Abstract]   [Full Text] [Related]  

  • 13. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
    Dorfman HL; Reig LP
    Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
    [No Abstract]   [Full Text] [Related]  

  • 14. Access to medication and drug company sales practices: setting priorities for critique and advocacy.
    Seiler N
    Am J Bioeth; 2003; 3(3):61. PubMed ID: 14594498
    [No Abstract]   [Full Text] [Related]  

  • 15. The National Childhood Vaccine Injury Act and the supreme court's interpretation.
    Blake V
    Virtual Mentor; 2012 Jan; 14(1):31-4. PubMed ID: 23116914
    [No Abstract]   [Full Text] [Related]  

  • 16. Free lunch?
    Hill KP
    Am J Psychiatry; 2006 Apr; 163(4):569-70. PubMed ID: 16585426
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharma and CME: View from the US.
    Fletcher S
    BMJ; 2008 Aug; 337():a1023. PubMed ID: 18703647
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward.
    Kravitz RL; Bell RA
    Clin Pharmacol Ther; 2007 Oct; 82(4):360-2. PubMed ID: 17851573
    [No Abstract]   [Full Text] [Related]  

  • 19. The physician and the pharmaceutical industry: both must keep the patient's interests at heart.
    Ravindran GD
    Issues Med Ethics; 1999; 7(1):21-2. PubMed ID: 16320467
    [No Abstract]   [Full Text] [Related]  

  • 20. These two make quite a team.
    Kassirer JP
    Washington Post; 2004 Oct; ():B1, B5. PubMed ID: 15700368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.